This course has expired. View available courses.
Endocrinology
Individualizing of Antihyperglycemic Agents in Type 2 Diabetes – Specialists
In this program we discuss the determination of how specific patient factors can help with the individualization of antihyperglycemic therapies
DURATION
15 minutes
PROFESSION
Specialist
# OF CREDITS
0.25
ACCREDITATION
MOC - Section 1
EXPIRY DATE
2020-11-26
In this program we discuss the determination of how specific patient
factors can help with the individualization of antihyperglycemic therapies
Faculty
David C.W. Lau (MD, PhD, FRCPC) David Strain (MB, ChB, BSc (Hons) MD, FRCP) Deanna Telner (MD, CCFP) Elizabeth Rosolowsky (MD, MPH, FAAP, FRCPC) Jeffrey Habert (MD, CCFP, FCFP) John Axler (MD, CCFP, FCFP) Peter J. Lin (MD, CCFP) Robyn L. Houlden (MD, FRCPC) Thomas Round (MBBS, BSc, DRCOG, MRCGP) |
Learning objectives
Upon completion of this program, participants will be able to:
1. Customize quickly and easily antihyperglycemic therapy for patients